UVEITIS (IRITIS)
o Anterior = inflammation of iris (iritis) or ciliary body (cyclitis)
o Posterior = choroid inflammation
ETIOLOGIES = systemic inflammatory diseases (spondyloarthropathies, sarcoid, Behcets), or Infectious (CMV, syphilis, TB, toxoplasmosis), trauma, etc.
SIGNS/SYMPTOMS
o Anterior = Unilateral ocular pain, redness, photophobia, excessive tearing
- Anterior usually occurs after blunt trauma
o Posterior = blurred / decreased vision
so anterior uveitis = pain
posterior uveitis = blurry/decreased vision, no pain
PHYSICAL EXAM
TREATMENT
- steroids
Anterior = topical steroids, Scopolamine, topical cycloplegics
Posterior = systemic steroids
MARCUS GUNN PUPIL (RELATIVE AFFERENT PUPILLARY DEFECT)
during swinging flashlight test: when light is shone into unaffected eye, the affected eye will also constrict
when light shone into affected eye = dilates, or only slightly constricts (so does other eye)
Test = perform the “SWINGING FLASHLIGHT TEST”
RAPD = ray (light) in affected pupil = dilates
ex: Left Afferent Pupillary Defect = When it is directed at the left eye, both pupils are 3 mm. When swung to the right eye, both pupils constrict to 2.5 mm. When swung back to the left eye, both pupils dilate back to 3 mm
Seen in OPTIC NEURITIS
ARGYLL-ROBERTSON PUPIL
pupil constricts with accommodation (switching from near to far) but DOES NOT react to bright light
MC CAUSE = NEUROSYPHILIS***
VISUAL PATHWAY DEFECT
a blindness or reduction in vision in one half of the visual field due to damage of the optic pathways in the brain.
decreased vision or blindness in half the visual field. can occur in one eye or both eyes
homonymous hemianopsia = both right sides or both left sides of visual fields are decreased/blind
(due to damage of optic tract on one side); if damage on the optic tract on the left side = goes to the left side of both eyes = then lose vision on right side of both eyes
if damage to optic tract on the right side = goes to the right side of both eyes = then lose vision in the left side of both eyes
if damage at the optic chiasm (where cross-over occurs) = goes to the inner vision of both eyes = then lose vision on lateral sides of both eyes = bitemporal heteronymous hemianopsia
if damage at the optic nerve = supplies both the inner and outer vision of the same eye –> monocular blindness
ACUTE SINUSITIS
The major organisms associated with bacterial acute sinusitis is streptococcus pneumonia, H. influenzae, and M. Catarrhalis.
With the patients history of anaphylaxis with penicillin, the best choice is D bactrim
LYME DISEASE
multi-system bacterial infection
highest likelihood of transmission = tick is engorged and/or has been attached for at least 72 hours
SYMPTOMS
DIAGNOSIS = clinical: especially in early Lyme disease = based on presence of EM rash, hx of tick bite and arthritis; patients with EM rash are often seronegative in early stage
TREATMENT = Doxycycline 100mg BID x 10-21 days.
Late/severe disease = IV Ceftriaxone if patient is experiencing 2nd/3rd degree AV heart block, syncope, dyspnea, chest pain, CNS disease (meningitis)
NEED FOR PREVENTATIVE TREATMENT?
MOLLUSCUM CONTAGIOUSUM
benign viral infection of the skin
highly contagious*
POXVIRUS (poxviridae family)
MC in children, sexually active adults, and immunocompromised patients (HIV)
SPREAD VIA
⦁ skin to skin contact (MC)
⦁ Fomites
usually asymptomatic**
RISK FACTORS ⦁ children sharing baths ⦁ athletes sharing gym equipment ⦁ camp / school / public recreational places (pools) ⦁ *** swimming pools *** ⦁ sexual activity / HIV
CLINICAL MANIFESTATIONS
⦁ ** Discrete 2-5mm, UMBILICATED, DOME-SHAPED, FLESH-COLORED, WAXY PAPULES
⦁ ** CENTRAL UMBILICATION **
DIAGNOSIS
⦁ clinical (appearance)
⦁ may biopsy if uncertain
- will show keratin in central depression
- molluscum bodies, or Henderson-Paterson bodies are seen on histologic examination findings
TREATMENT
⦁ NONE!!! will spontaneously resolve on its own - in about 3-6 months
⦁ other options = curettage, cryotherapy, cantharidin, podophyllin (for HPV warts), cautery, Imiquimod, TCA (trichloracetic acid), topical retinoids, Cimetidine (antiviral; usually antihistamine - H2 blocker, Tagamet - used for PUD/GERD)
ROSACEA
Chronic acneiform disorder of facial pilosebaceous units
EXACERBATING ROSACEA FACTORS ⦁ hot liquids ⦁ spicy foods ⦁ alcohol ⦁ exposure to sun & heat ⦁ exercise
CLINICAL PRESENTATION OF ROSACEA
⦁ redness to cheeks, nose and chin
⦁ burning or stinging with episodes
⦁ skin dryness, edema
The nose, cheeks, forehead, chin, and glabella are the most commonly affected areas.
Clinical features include flushing, telangiectasias, erythema, papules and pustules, and rhinophyma.
More than 50% of patients with rosacea have ocular manifestations, and ocular findings may be the first manifestation of rosacea in some patients.
Variable erythema and telangiectasia are seen over the cheeks and the forehead. Inflammatory papules and pustules may be predominantly observed over the nose, the forehead, and the cheeks.
Prominence of sebaceous glands may be noted, with the development of thickened and disfigured noses (rhinophyma) in extreme cases. Unlike acne, patients generally do not report greasiness of the skin; instead, they may experience drying and peeling. The absence of comedones is another helpful distinguishing feature.
Rhinophyma may occur as an isolated entity, without other symptoms or signs of rosacea. Rhinophyma can be disfiguring
Manifestations of ocular rosacea range from minor irritation, foreign body sensation, dryness, and blurry vision to severe ocular surface disruption and inflammatory keratitis. Patients frequently describe a gritty feeling, and they commonly experience Blepharitis and conjunctivitis. Other ocular findings include lid margin and conjunctival telangiectasias, eyelid thickening, eyelid crusts and scales, chalazia and hordeolum, punctate epithelial erosions, corneal infiltrates, corneal ulcers, corneal scars, and vascularization
Ocular rosacea is most frequently diagnosed when patients also suffer from cutaneous disease. However, ocular signs and symptoms may occur prior to cutaneous manifestations in 20% of patients with rosacea
4 SUBTYPES OF ROSACEA ⦁ erythematotelangiectatic rosacea ⦁ papulopustular rosacea ⦁ phymatous rosacea (large nose) ⦁ ocular rosacea
TREATMENT FOR ROSACEA
use gel or creams
Azelaic acid
Metronidazole - most common
Erythromycin
Clindamycin
Brimonidine (Mirvaso) = alpha -2 agonist = vasoconstrictor; best for facial flushing / persistent redness) - brimonidine can also be used for acute angle closure glaucoma
Topical Ivermectin cream (Soolantra) = for ppl who get papulopustular acneiform rosacea due to being immunologically sensitive to mites
SYSTEMIC ANTIBIOTICS = for mod/severe rosacea
⦁ Tetracycline
⦁ Doxycycline / Minocycline
⦁ Erythromycin
FACIAL REDNESS/FLUSHING TX = BRIMONIDINE (MIRVASO)
PAPULOPUSTULAR DISEASE TX = metronidazole, azelaic acid, ivermectin (soolantra) = 1st line; can try sodium sulfacetamide
can do oral antibiotics for mod/severe = tetracyclines (doxy/tetra), oral metronidazole, oral ivermectin, sodium sulfacetamide
ACNE VULGARIS
ACNE = eruption VULGARIS = common
= “common eruption” of skin that occurs when hair follicles (pores) get blocked up/plugged with dead skin cells or oil
once the hair follicle is blocked ==> forms red raised bump on the skin
Acne = particularly common among teenagers because of skin changes that occur during puberty
DIFFERENT TYPES OF ACNE
⦁ mild acne = whiteheads + blackheads
⦁ moderate acne = pustules
⦁ severe acne = cysts + nodules
3 MAIN LAYERS OF SKIN
⦁ epidermis (5 sublayers) = “Come Lets Get Some Beer”
- stratum corneum = outermost
- stratum lucidum = in palms + feet (thicker)
- stratum granulosum
- stratum spinosum = thickest layer
- stratum basale
⦁ dermis
When arrector pili muscle contracts, sebum gets squeezed out
⦁ hypodermis
- made of fat and connective tissue that anchors the skin to the underlying muscle
CAUSE OF ACNE - not fully understood - combination of factors
⦁ keratin plugs
⦁ sebum
⦁ bacterial overgrowth
- 4 factors involved ⦁ follicular hyperkeratinization ⦁ increased sebum production ⦁ Propionibacterium acnes within the follicle ⦁ inflammation
1) KERATIN PLUGS
- dead keratinocytes (dead skin cells) + keratin + melanin
- when hair follicles and keratinocytes overproduce keratin (hyperkeratosis), –> leads to more keratin plugs forming –> blocks opening of hair follicle (pore)
- clogged sebaceous glands due to increased proliferation of follicular keratinocytes
2) SEBUM
- released by sebaceous glands in response to increased androgen hormone production that is released during puberty
- also causes blockage of pore, just like keratin plug
3) BACTERIAL OVERGROWTH
- when excess of keratin plugs or sebum or both ==> can start to fill up a hair follicle (pore), but doesn’t quite plug it up all the way
- if hair follicle is still open to the surface of the skin (open comedo = blackhead)
Triglycerides in the sebum (large component of sebum) particularly is what the bacteria love to thrive on
CAUSES OF ACNE
- genetic + environmental factors
⦁ hyperkeratosis (genetic component)
⦁ hormones (ex: PCOS - increased androgen levels) (ex: Cushing’s disease = increased androgens)
⦁ products (can block pores)
⦁ behaviors (ex: wearing a headband) (ex: excessive face washing –> irritation –> more acne)
⦁ psychological stress –> increased cortisol –> increased sebum secretion
⦁ certain foods (dairy or chocolate)
acne can affect one’s physical appearance / confidence –> leads to more stress –> leads to more acne / etc.
wearing a headband / helmet / hat etc = contact acne (ACNE VENENATA)
HORMONES - increased androgen levels
Acne vulgaris is thought to be an insulin-like growth factor 1 mediated disease
⦁ Milk products
⦁ hyperglycemia
⦁ smoking
- can all lead to increased insulin-like growth factor 1
Insulin-like growth factor is thought to activate the 5-alpha-reductase enzyme for conversion of testosterone to dihydrotestosterone. It also stimulates androgen release by the adrenal gland and gonads as well as androgen receptor signal transduction. These factors together may stimulate the eruption of acne lesions.
Elevated testosterone and exogenous supplementation of testosterone have also been associated with acne formation. Because hormone levels are elevated and labile in adolescents, this is a significant cause of acne in teens
Androgens, not estrogens, stimulate the growth and secretion of the sebaceous glands. In teenagers, comedonal acne correlates with the rise of dehydroepiandrosterone (DHEA) serum levels.
androgens are what kick off the sebaceous glands -> increased sebum production. DHEA (precursor of testosterone) is what increases sebum production –> seborrhea.
No androgens = no acne
ACNE VULGARIS MC OCCURS ON LOCATIONS OF ⦁ face / neck ⦁ shoulders ⦁ chest ⦁ back - sites of oil glands
4 TYPES OF ACNE VULGARIS (based on severity)
⦁ type I (mild acne) = no scarring, and has few small comedones, may have some papules / pustules
⦁ type II (moderate acne) = no scarring, larger comedones / larger amounts of papules / pustules
⦁ type III (moderately severe acne) = some scarring, have papular and pustular acne
⦁ type IV (severe) = severe scarring and nodulocystic acne - invades deeper into the dermis
TREATMENT - depends on severity
⦁ type I (mild acne)
- topicals such as benzoyl peroxide or salicylic acid - decreases P. acne concentration, removes the top keratin layer, reduces inflammation. SE = erythema / dermatitis
⦁ mild to moderate = topical retinoids, topical antibiotics, benzoyl peroxide
⦁ type II (moderate acne) = topical retinoids, oral abx such as doxycycline / minocycline / bactrim
- spironolactone for hormonal regulation
⦁ type III and IV = isotretinoin (Accutane) = oral retinoid = synthetic vitamin A derivative - affects sebum secretion
- SE = teratogenicity
Spironolactone = decreases androgen –> reduces sebum production
ISOTRETINOIN - affects all 4 MOA of acne!
the effect of most phototoxic medications is through their activation by UVA light (which comprises 95% of all UV light we receive from the sun).
TREATMENT FOR ACNE SCARS
- retinoids, peels, microdermabrasion, lasers
PSORIASIS
H
ECZEMA
H
SERONEGATIVE SPONDYLOARTHROPATHIES
SERONEGATIVE SPONDYLOARTHROPATHIES
Seronegative = RF not found in the blood
⦁ Young male predominance: < 40 ⦁ inflammatory arthritis ⦁ uveitis and sacroiliitis ⦁ + HLA-B27 gene susceptibility ⦁ Negative ANA and RF ⦁ + Enthesitis = inflammation where ligaments and tendons insert into bone
⦁ PEAR = Psoriatic Arthritis, Enteropathic Arthritis (IBD), Ankylosing Spondylitis, and Reiter’s or Reactive Arthritis
HUNTINGTON’S DISEASE
CHARACTERIZED BY:
⦁ Behavioral / Psychological changes
⦁ Chronic progressive chorea
⦁ Dementia
HTT (huntingtin gene) is affected, which encodes the protein huntingtin - on chromosome 4
HD expands the CAG trinucleotide in HTT gene (cytosine - adenine - guanine ) = glutamine - sequence is repeated longer than usual
MRI Findings with HD = Atrophy of caudate & putamen (neostriatem) = most prominent on MRI = can actually see this disease in an MRI
- also see ventricular enlargement
SIGNS/SYMPTOMS
SYMPTOMS (ADULT ONSET)
⦁ Chorea affects the limbs and trunk
⦁ Dystonia (involuntary contractions of muscles)
⦁ Rigidity
⦁ Postural instability
⦁ Myoclonus (quick, involuntary muscle jerk)
⦁ Nystagmus
SYMPTOMS (JUVENILE ONSET) ⦁ Very rare ⦁ Bradykinesia ⦁ Rigidity ⦁ Quicker progression
EARLY PSYCHOLOGICAL MANIFESTATIONS - behavioral changes: personality, cognitive, intellectual and psychiatric - including irritability ⦁ Depression ⦁ Personality changes - Memory loss - Impulsive behavior - Moodiness - Antisocial behavior - Emotional outbursts
OTHER EARLY SIGNS
⦁ lack of initiative
⦁ loss of spontaneity
⦁ inability to concentrate
EARLY PHYSICAL SIGNS
⦁ fidgeting
⦁ restlessness
LATER PHYSICAL SIGNS
⦁ chorea - rapid, involuntary or arrhythmic movement of the face, neck, trunk and limbs initially. Chorea worsens with voluntary movements and stress. Usually disappears with sleep
⦁ dystonic posturing
⦁ progressive rigidity
⦁ akinesia (absence/loss of control of voluntary movement)
⦁ dementia - most develop dementia before 50y/o
Death = often due to aspiration from pneumonia - due to discoordinated swallowing, or suicide.
PHYSICAL EXAM
DIAGNOSTIC STUDIES
CT SCAN = cerebral and caudate nucleus atrophy and increased ventricular size
- MRI = similar findings
⦁ MRI - shows caudate atrophy & increased ventricular size
⦁ Genetic Testing
- sensitive & specific
- easy confirmation of clinical diagnosis, diagnosis of atypical patients, and presymptomatic testing in at-risk individuals (confirmation of HD)
TREATMENT
⦁ Neuroleptics (antipsychotics) - deplete cerebral dopamine (Neuroleptics (antipsychotics) act by blocking dopamine transmission, and have the potential benefit of treating both chorea and certain psychiatric symptoms such as agitation and psychosis
⦁ Risperidone (Risperdal)
⦁ Olanzapine (Zyprexa)
⦁ Aripiprazole (Abilify)
Anticonvulsants
⦁ Clonazepam (Klonopin)
⦁ Valproic Acid (Depakote)
Antidepressants for depression
⦁ Fluoxetine (Prozac)
⦁ Sertraline (Zoloft)
⦁ Nortriptyline (Aventyl, Pamelor)
PARKINSON’S DISEASE
PD tends to affect older populations - usually hits around age 60, but younger onset can occur
PD = Leading cause of neurologic disease in patients over 65 - usually begins after age 50, but can occur at earlier stages
- the earlier the onset of symptoms = worse prognosis
PATHOPHYSIOLOGY
-Dopamine depletion from the basal ganglia - results in the major disruption in connections to the thalamus & motor cortex
loss of dopaminergic nerve terminals in substantia nigra - primarily D1 + D2 receptors are relevant in PD (5 types of dopamine receptors: D1-D5)
- Also relative increase in cholinergic interneuron activity occurs due to degeneration of dopamine pathways, which contributes especially to tremor
LEWY BODIES - believed to be the pathological hallmark of PD
POSSIBLE CAUSES / RISK FACTORS FOR PD ⦁ primary cause = unknown ⦁ family history ⦁ genetics - Parkin gene was found with early-onset Parkinson's ⦁ immunologic & inflammatory factors ⦁ aging
FACTORS THAT REDUCE THE RISK OF PD ⦁ caffeine intake ⦁ moderate to vigorous physical activity ⦁ statin use & lipid levels...? (unsure) ⦁ NSAID use...? (unsure)
SIGNS/SYMPTOMS
⦁ Tremor
- occurs in 75% of ppl with PD
- tremor = the most visible manifestation with PD***** - usually affects distal segment of limbs - mainly hands & feet
- called “pill rolling”
- tremor = usually unilateral & appears at rest, disappears with movement & sleep
⦁ Rigidity
⦁ Akinesia
⦁ Postural Instability
OTHER SYMPTOMS OF PARKINSON'S DISEASE ⦁ Emotional and voluntary facial movements become limited and slow leading to a “mask like” facies - lack expression ⦁ Loss of blinking reflex ⦁ Tongue, palate and throat muscles become rigid --> leads to drooling ⦁ Uncontrolled sweating ⦁ Sebaceous gland secretion - Seborrhea ⦁ Micrographia (small writing) ⦁ Hypophonia (weak voice due to diminishing vocal muscles) ⦁ Depression ⦁ Orthostatic hypotension ⦁ Constipation ⦁ Impotence ⦁ Urinary incontinence ⦁ Dementia
DIAGNOSIS OF PD
RATING SCALE FOR PD
UPDRS = Unified Parkinson’s Disease Rating Scale
⦁ I. Mentation / Behavior / Mood
⦁ II. Activities of Daily Living (subjective)
⦁ III. Motor Examination (objective)
⦁ IV. Complications of Therapy
TREATMENT
PD TREATMENT - catered towards increased dopamine levels - as normally high concentrations of dopamine in the basal ganglia is reduced in Parkinsonism
- Pharm tx = given in attempts to restore dopamine activity in brain, as well as manage SE of dopaminergic therapy
1) LEVODOPA / CARBIDOPA (SINEMET)
“GOLD STANDARD OF TREATMENT” = traditionally used 1st line, very effective
- Sinemet tends to be less effective with prolonged use in some patients - build up tolerance over time, which is why you ideally want to hold off on Sinemet for as long as you can
SE of Sinemet = ⦁ low BP (opposite of MAOB inhibitors)
⦁ dizziness ⦁ HA ⦁ insomnia ⦁ arrhythmia
⦁ GI effects - N / V / D / C
⦁ hair loss ⦁ Dyskinesias*** - (80%) - more common when used in younger patients
⦁ confusion ⦁ anxiety ⦁ vivid dreams / hallucination
To try & prevent these SE - try giving Sinemet in smaller doses more frequently
- reduce or stop evening dose if severe psychiatric effects occur
2) MAOB- INHIBITORS
⦁ SELEGILINE (Eldepryl, Zelapar) (older & more SE)
⦁ RASAGILINE (Azilect)
MOA = - stops the breakdown of dopamine; MAOB breaks down dopamine, so MAOB-inhibitors prevent the breakdown of dopamine
- MAOB inhibitors enhance levadopa levels
3) DOPAMINE AGONISTS ⦁ Bromocriptine (Parlodel); Pergolide (Permax) = older = ergo derivatives ⦁ Pramipexole (Mirapex) ⦁ Ropirinole (Requip) ⦁ Rotigotine (Neupro) = patch
MOA
***Dopamine agonists are typically avoided in the ELDERLY due to significant SE
Rotigotine (Neupro) = transdermal patch - available because of diminished ability to swallow with PD
4) COMT INHIBITORS
⦁ ENTACAPONE (COMTAN)
⦁ TOLCAPONE (TASMAR)
*** - COMT inhibitors reduces the need for levadopa/carbidopa, but CAN ONLY BE USED in patients who are taking levadopa / carbidopa - but often able to decrease Sinemet dose
MOA
- COMT breaks down levodopa in the periphery. COMT inhibitors prevent the breakdown of levodopa in the periphery, therefore increasing the levodopa concentration, leading to more dopaminergic stimulation of the brain (COMT inhibits MAOB from degrading levodopa)
Entacapone (Comtan) used more than Tolcapone (BBW for hepatotoxicity - have to check LFTs every 2 weeks x 6 months & need written documentation of consent)
STALEVO = combo of Levadopa / Carbidopa (sinemet) + Entacapone
5) AMANTADINE (SYMMETREL)
MOA = unknown - thought to inhibit NMDA receptors to potentiate dopaminergic responses
Indications = for mild symptoms or for treatment of levodopa induced dyskinesia (given in addition to levodopa/carbidopa to treat SE of dyskinesia)
*USE AMANTADINE WITH CAUTION IN RENAL DYSFUNCTION
Block acetylcholine = anticholinergic drugs (sympathetic
⦁ TRIHEXYPHENIDYL (ARTANE)
⦁ BENZTROPINE (COGENTIN) - reverses extrapyramidal symptoms SE from antipsychotics
Can give anticholinergics to restore balance between dopamine (low) and acetylcholine (which is now relatively high - has not increased, but is high compared to dopamine - which levels should be balanced).
CONTRAINDICATIONS TO ANTICHOLINERGICS
⦁ BPH
⦁ Obstructive GI disease
⦁ Angle closure glaucoma (also a CI to Sinemet)
MYASTHENIA GRAVIS
MOA = Inefficient skeletal muscle neuromuscular transmission due to developing autoimmune autoantibodies against acetylcholine (nicotinic) receptors (AchR-Ab) at neuromuscular junction —> this leads to a destruction of ACh receptors = a decrease in the number of acetylcholine receptors available because of AchR-Ab binding.
EPIDEMIOLOGY
CLINICAL PRESENTATION
- 2 categories = 1) Ocular + 2) Generalized muscle weakness
o OCULAR WEAKNESS
⦁ usually the 1st presenting symptom, and is more severe than generalized
⦁ weakness of EOM –> DIPLOPIA, PTOSIS (more prominent in upward gaze)
⦁ weakness is worsened with repeated EOM use; pupils are spared
⦁ “Curtain Sign = The clinical examiner might also try to elicit the “curtain sign” in a patient by holding one of the person’s eyes open, which in the case of MG will lead the other eye to close
o GENERALIZED MUSCLE WEAKNESS
⦁ least in the morning; worsened with repeated muscle use throughout the day; relieved with rest
⦁ have normal sensation and normal DTRs
⦁ BULBAR (OROPHARYNGEAL WEAKNESS) = Jaw weakness, especially with prolonged chewing. Dysphagia, Dysarthria. Weakness of orbicularis oris muscle –> “Myasthenic Sneer” - lost their smile, patient appears expressionless
⦁ RESPIRATORY MUSCLE WEAKNESS = may lead to respiratory failure / risk of aspiration = Myasthenic crisis
⦁ weight of head overcomes extensors –> results in “dropped head syndrome”
⦁ limbs have proximal weakness - arms are more affected than legs
⦁ wrist and finger extensors and foot dorsiflexors involved
CLINICAL COURSE
DIAGNOSIS
Electrodiagnostic studies
All patients should have a CT to rule out thymic enlargement or thymoma with MG. Xray may detect enlargement/thymoma, however, a negative xray does not rule this out…
TREATMENT
- 1st line = Pyridostigmine or Neostigmine = Acetylcholinesterase Inhibitors - increases acetylcholine receptors by decreasing breakdown via acetylcholinesterase.
SE = abdominal cramps, diarrhea, cholinergic crisis (weakness, N/V, pallor, sweating, salivation, diarrhea, miosis, bradycardia, respiratory failure)
GUILLAIN-BARRE SYNDROME
PATHOPHYSIOLOGY = - usually provoked by preceding infection - acute immune-mediated demyelination and axonal degeneration that slows nerve impulses –> leads to symmetric weakness and paresthesias. A post-infection immune response cross-reacts with peripheral nerve components * Causes generation of antibodies to gangliosides that cause axonal injury or immune response to myelin. Usually presents 2-4 weeks after infection
***PRECEDED BY INFECTION
- usually Campylobacter Jejuni (MC)
Others = respiratory or GI infections, CMV, EBV, HIV, mycoplasma
- small % of GBS result from immunizations, surgery, trauma + bone marrow transplant
CLINICAL MANIFESTATIONS
- ASCENDING WEAKNESS + PARESTHESIAS - usually SYMMETRIC
- decreased DTR (LMN lesion)
- may involve muscles of respiration or bulbar muscles (swallowing abnormalities); CN VII palsy
- Autonomic dysfunction –> Tachycardia, Hypo or hypertension, Breathing difficulties
⦁ Symmetric (Bilateral) ASCENDING muscle weakness with ABSENT / DECREASED DTRs; weakness usually starts in proximal legs
⦁ severe respiratory muscle weakness - 30% of patients require ventilator support
⦁ Paresthesias in hands/feet = common (80%); sensory abnormalities on examination are frequently mild
⦁ Often prominent severe back pain
⦁ Dysautonia (70%) = ANS doesn’t work properly => tachycardia, bradycardia, urinary retention, HTN alternating with hypotension, orthostatic hypotension, ileus, loss of sweating
DIAGNOSIS
o Lumbar Puncture (LP) - normal or xanthochromia (yellow)
- will show elevated CSF protein** (> 400)
- will have normal WBC count in CSF
- will have normal glucose
= known as ALBUMINOCYTOLOGICAL DISSOCIATION
- high protein usually seen after 1-3 weeks of symptom onset
o Electrophysiologic studies = decreased motor nerve conduction velocities and amplitude
TREATMENT
- Plasmapheresis (best if done early) = removes harmful circulating auto-antibodies that cause demyelination. Equally as effective as IVIG
Uptodate = When both therapies are equally available and there are no contraindications for either, we suggest treatment with IVIG.
PROGNOSIS
- 60% have full recovery in 1 year; 10-20% have permanent disability
MULTIPLE SCLEROSIS
**The MOST common acquired disease of myelin
Autoimmune, inflammatory, demyelinating disease of the CNS
- Axon degeneration of WHITE MATTER of the brain, spinal cord and optic nerve
MC in women + young adults (20-40)
MS = autoimmune dz in which the body mistakenly directs antibodies + WBCs against proteins in the myelin sheath
The areas of demyelination are found scattered in the white matter of the
⦁ brain
⦁ spinal cord
⦁ optic nerve
PATHOGENESIS
- auto-immune mediated inflammatory demyelination + axonal injury
o peri-vascular infiltration by lymphocytes + monocytes
o MCH (major histocompatibility complex) antigen expression
o HLA-DR2 = increases risk
AREAS COMMONLY AFFECTED BY MS
⦁ Optic nerve (optic neuritis)
⦁ Corticobulbar tracts = affects speech + swallowing
⦁ Corticospinal tracts = affects muscle strength
⦁ Cerebellar tracts = affects gait + coordination
⦁ Spinocerebellar tracts = affects balance
⦁ Longitudinal fasciculus = affects conjugate gaze + EOMs
⦁ Posterior cell columns of spinal cord = affects proprioception + vibratory sense
EPIDEMIOLOGY
Geographical factors = more common in countries with temperate climates (Europe, southern canada, northern US, southeastern Australia); reason is unknown
Environmental Factors = many viruses + bacteria have been suspected of causing MS - most recently EBV**
SYMPTOMS OF MS
⦁ Lhermitte’s Symptoms = weakness / numbness / tingling / unsteadiness in a limb (barber chain phenomenon - an electrical sensation that runs down the back and into the limbs. In many patients, it is elicited by bending the head forward
⦁ unilateral visual impairment
⦁ fatigue
⦁ spastic paraparesis (spastic partial paralysis of lower limbs)
⦁ diplopia
⦁ disequilibrium
⦁ muscle weakness
⦁ sphincter disturbance - such as urinary urgency or hesitancy
⦁ dysarthria
⦁ mental disturbance - such as depression
SIGNS OF MS ⦁ Optic Neuritis = often the initial episode/sign of MS - pale disc, large cup to disc ratio ⦁ ophthalmoplegia ⦁ nystagmus ⦁ spasticity or hyperreflexia ⦁ Babinski sign ⦁ absent abdominal reflexes ⦁ labile or changed mood
1) SENSORY DEFICITS
- pain
- fatigue
- numbness
- paresthesias in limbs
- muscle cramping
TRIGEMINAL NEURALGIA = chronic pain disorder that affects the trigeminal nerve; Symptoms include facial pain, difficulty in chewing, speaking, and brushing
UHTOFF’S PHENOMENON = worsening of symptoms with heat = exercise, fever, hot tubs
LHERMITTE’S SIGN = neck flexion causes shock pain that radiates from spine down the leg
2) OPTIC NEURITIS
- Marcus Gunn Pupil - during swinging flashlight test = affected eye dilates with light and constricts without light
3) MOTOR = UPPER MOTOR NEURON INVOLVEMENT
- spasticity
- positive (upwards) Babinski
4) SPINAL CORD SYMPTOMS
- Bladder, Bowel or Sexual dysfunction
5) CHARCOT’S NEUROLOGIC TRIAD
- Nystagmus
- Staccato speech
- Intentional tremor
The majority of patients have resolution of their initial symptoms, but then fall into the following pattern:
⦁ RRMS (Relapsing–Remitting MS) - there is an interval of months to years after the initial episode before new symptoms develop or original symptoms reoccur
⦁ RRMS = type of MS seen in the majority of patients
4 TYPES OF MS
DIAGNOSIS
- MRI - IV Gadolinium enhances acute lesions
MRI of head or cervical cord = clinically definite in 85% of MS patients
- hx, PE, neurological exam, signs/symptoms
CT = not helpful
CSF can be helpful when an MRI is not confirmatory = usually normal, but can show - high protein, high lymphocytes, high IgG, myelin antibodies, and oligoclonal bands
o test results can be altered in a variety of inflammatory neurologic disorders, so CSF results are not specific for MS; do CSF if hx/PE/signs/symptoms = suspicious of MS, but MRI is negative
PROBABLE DIAGNOSIS OF MS
- multifocal white matter disease, but only 1 clinical attack…or a history of at least 2 clinical attacks but signs of only 1 lesion
KURTZKE EXPANDED DISABILITY STATUS SCALE (EDSS) = used to measure disease progression by assigning a severity score (0-10) to patient’s clinical status
TREATMENT
1) STEROIDS = mainstay of tx for acute attacks
- helps to reduce inflammation + improve nerve conduction. Long term administration of steroids does not alter the course of the disease, however, and long term use can have harmful SE
2) PLASMAPHARESIS (plasma exchange) = treatment for acute exacerbations that are not responsive to steroids; Plasma is removed from blood, to remove antibodies to myelin, mixed with albumin, then put back in
IMMUNE MODIFIERS
⦁ Interferon 1a
⦁ Interferon 1b
⦁ Glatiramer acetate
DRUGS FOR PROGRESSIVE MS = IMMUNOSUPRRESSANTS ⦁ Glatiramer acetate (Copaxone) ⦁ Dimethyl fumarate (Tecfidera) ⦁ Fingolimod (Gilenya) ⦁ Teriflunomide (aubagio) ⦁ Natalizumab (Tysabri) ⦁ Alemtuzumab (Lemtrada) ⦁ Miloxantrone
Amantadine (anti-viral - also used in parkinsons) = helpful for fatigue in MS
ADHD
has to affect them in different areas of their life, in multiple settings: school/work, home, etc.
Manifests in childhood with symptoms of hyperactivity, impulsivity and/or inattention
Symptoms affect cognitive, academic, behavioral, emotional and social functioning
these patients experience their emotion in a more intense fashion; may seem to be an “inappropriate reaction” to a stress
Now realizing that ADHD can manifest in adults who didn’t show symptoms as a child; instead of school functioning issues, impulsivity/inability to follow through with tasks at work, multiple job changes, unhappiness at work/failure at work; mostly productivity
ADHD = one of the most common disorders of childhood
Having oppositional defiant disorder / uconduct disorder = more likely to also have ADHD. Same with kids who have anxiety disorder and learning disabilities
More prevalent in males
ADHD = frequently associated with other psychiatric disorders
NEUROPATHOGENESIS OF ADHD
- brain imaging reveals decreased activation in areas of basal ganglia & anterior frontal lobe
The sensory information gets unorganized and unfiltered; it’s difficult for ppl with ADHD to filter info and store it properly –> so move around a lot, or are doing other things while listening or looking elsewhere but still able to process what’s going on
Too little dopamine (like parkinson’s) - so need medication that will increase dopamine
FRONTAL LOBE = ability to project future consequences resulting from current actions, and being able to choose between good and bad decisions (or even between better and best choices).
- Frontal lobe also allows for the override + suppression of socially unacceptable responses, and the determination of similarities + differences between things/events
DIFFERENCE IN BRAIN FUNCTION OF THOSE WITH ADHD
THE BASIS OF TREATMENT OF ADHD WITH METHYLPHENIDATE***
⦁ increases extracellular dopamine + NE in the brain
⦁ changes the areas of function in the frontal lobe
⦁ in patients without ADHD, methylphenidate does NOT have the same effect on the frontal lobe function
CRITERIA FOR DIAGNOSIS
ADHD INATTENTIVE SYMPTOMS
⦁ Easily distracted; miss details, frequently switch from one activity to another, forget things. Easily distracted when multiple things are happening simultaneously
⦁ Difficulty maintaining focus on one task or learning something new
⦁ Failure to give close attention to detail; misses details, may make careless mistakes
⦁ Failure to listen when spoken to directly, Failure to follow instructions
⦁ Difficulty organizing tasks and activities; difficulty completing assignments
⦁ Reluctance to engage in tasks that require sustained mental effort
⦁ Forget things or lose things needed to complete activities and tasks (pencil); (did my hw, but I lost it - very common with ADHD).
⦁ Forgetfulness in daily activities
⦁ Becomes bored with a task after a few minutes, unless doing something enjoyable
ADHD IMPULSIVE-HYPERACTIVITY SYMPTOMS
⦁ Fidgetiness with hands and feet or squirms in seat
⦁ Constantly in motion; may often leave their seat - difficulty remaining seated in class
⦁ Has trouble sitting for long periods (ex: doing homework, dinner, school)
⦁ Difficulty doing quiet tasks
⦁ Often talks excessively or non-stop
⦁ Excessive talking and blurting out answers before questions have been completed
⦁ Impatience
⦁ Excessive running or climbing in inappropriate situations; Dashes around, touching or playing with everything in sight
⦁ Restlessness
⦁ Blurts out appropriate or inappropriate comments; shows unrestrained emotions
⦁ Difficulty in engaging in quiet activities
⦁ Is often “on-the-go” or acts as if “driven by a motor”
⦁ Difficulty awaiting turns (while waiting in line)
⦁ Interrupting and intruding on others; Interrupts the conversation or activities of others
MEDICAL EVALUATION FOR ADHD
- Parents + Teacher need to fill out form - such as the Vanderbilt form
- Refer for vision & hearing tests* - r/o that kid isn’t just having difficulty seeing or hearing at school
- Complete hx, ROS, and PE to rule out other causes / psych illnesses
- If history suggests, may consider the following
⦁ blood lead level
⦁ TSH
⦁ sleep study
⦁ neurology consult if concern for seizures or other neurologic disorder
Poor sleep quality can lead to ADHD-like symptoms or learning disabilities; so ask about snoring, look in mouth (tonsils), large neck, obesity, etc.
DIAGNOSIS + TREATMENT OF ADHD IN ADULTS
often kids with ADHD are able to come off the med as an adult due to decrease in symptoms; unsure if changes in brain development or whether due to adaptation to ADHD over time
ADHD TREATMENT
TREATMENT OF ADHD
1) = Behavior modification
2) Sympathomimetic medications = Stimulants = PHARM TREATMENT OF CHOICE
⦁ Ritalin (Methylphenidate) = Concerta
⦁ Adderall (Amphetamine; Dextroamphetamine)
⦁ Focalin (Dexmethylphenidate)
CRITERIA FOR INITIATION OF THERAPY
⦁ Complete diagnostic assessment that confirms ADHD
⦁ ≥ 6 years old
⦁ Parental consent
⦁ School is cooperative (if dosing during school hours)
⦁ No previous sensitivity to the chosen medication
⦁ Normal heart rate and BP
⦁ No history of seizure disorder (if so refer to neurology to treat ADHD too)
⦁ Does not have Tourette syndrome, Autism spectrum disorder, anxiety disorder, or substance abuse among household members
if there is a hx of substance abuse in household members, can prescribe a non-stimulant therapy
PRETREATMENT WORK UP
o need a comprehensive medical evaluation (above info) + EKG to r/o arrhythmia
o document pretreatment height / weight / BP / HR
o document the presence of any of the following symptoms PRIOR to treatment
⦁ general appetite
⦁ sleep pattern
⦁ headaches
⦁ abdominal pain
o assess for substance use or abuse
⦁ need treatment for this before starting ADHD meds
ADHD PHARMACOTHERAPY
Choice of Agent (If patient and parents agree to medications)
o Stimulants are first line agent
⦁ Methylphenidate (Ritalin) (Concerta)
⦁ Dextroamphetamine (Adderall)
- Dexmethylphenidate (Focalin)
o Atomoxetine (Strattera) is an alternative (non stimulant)
CONSIDERATIONS THAT MAY AFFECT MEDICATION CHOICE IN ADHD
⦁ Daily duration of coverage needed
⦁ Completion of homework or driving after school?
⦁ Ability of child to swallow pills or capsules
⦁ Time of day when target symptoms occur
⦁ Desire to avoid administration at school
⦁ Coexisting tic disorder (avoid stimulants)**
⦁ Coexisting emotional or behavioral condition
⦁ Potential adverse effects
⦁ History of substance abuse in patient or household member (avoid stimulants)
⦁ Expense (short acting stimulants are least expensive)**
SHORT ACTING STIMULANTS: o METHYLPHENIDATE - Ritalin + Methylin = short acting -available in tablet, chewable tablet or liquid - onset of action = 20-60 minutes - duration of action = 3-5 hrs
o SHORT ACTING AMPHETAMINES = Adderall
LONG ACTING STIMULANTS: o METHYLPHENIDATE - Metadate ER, Methylin ER & Ritalin SR - onset of action: 20-60 minutes - duration of action = 8hrs
CONCERTA = osmotic release = Immediate release on the outside then uses an osmotic pump to slowly release medication
QUILLIVANT = liquid DAYTRANA = patch
o LONG ACTING AMPHETAMINES
Methylphenidate, dexmethylphenidate and amphetamines are equally effective
Have similar side effect profiles
Short acting agents
⦁ Initial rx in children < 6 (short acting methylphenidate = ritalin or methylin)*******
⦁ Or can be used to determine optimal dosing before switching to a long acting agent
Longer acting preparation
⦁ May be used initially in age > 6
⦁ Starting at the lowest dose and titrating up
Dose Titration: know that the initial dose is not necessarily the effective dose, so need to titrate up, and education patient/parents that drug won’t be effective until reach effective dose, but important to start on lower dose initially
NONSTIMULANT MEDS o Atomoxetine (Strattera) = alternative (non-stimulant) = 2nd line = SNRI = blocks NE reuptake - only increases NE release, not dopamine
FOLLOW UP
EVALUATE FOR THESE SIDE EFFECTS AT EACH FOLLOW UP
⦁ Decreased appetite*
⦁ Poor growth* (take summer drug holidays)
⦁ Dizziness (monitor BP)
⦁ Insomnia/Nightmares
⦁ Mood lability (can occur when drug is wearing off - consider switching to longer acting or increasing to BID or TID)
⦁ Rebound
⦁ Tics
⦁ Psychosis
⦁ Diversion and misuse
REASONS FOR TREATMENT FAILURE
o Can try another stimulant medication
o if pt fails multiple stimulants or experiences intolerable side effects = try Atomoxetine (Strattera) or an alpha-2 adrenergic (Clonodine - Cataprex) (Guanfacine - Tenex)
DRUG HOLIDAYS
MAINTENANCE OF THERAPY
TERMINATION OF THERAPY
both ritalin & adderall can cause anxiety, weight loss, psychosis and heart problems in at risk pts. High potential for addiction and abuse
DEXTROAMPHETAMINE (DEXEDRINE)
LISDEXAMFETAMINE (VYVANSE)
ATOMOXETINE (STRATTERA)
**BBW - INCREASED RISK OF SUICIDAL BEHAVIOR IN PTS < 25 **
MOST COMMON SE
⦁ dry mouth, insomnia, nausea, decreased appetite, constipation, decreased libido/ED, urinary hesitancy, dizziness, sweating
GUANFACINE (INTUNIV)
**so if pt has ADHD + HYPERTENSION = give Guanfacine (Intuniv)
SE can become hypotensive
*Caution with KIDNEY OR LIVER DISEASE **
BUPROPION (WELLBUTRIN)
ESSENTIAL TREMOR
Essential Familial Tremor (Benign)
WHICH BODY PARTS ARE AFFECTED
⦁ neck & head muscles
⦁ muscles of the voice
⦁ muscles of the arms & hands
THE TREMOR IS AGGRAVATED BY
⦁ stress
⦁ sleep deprivation
⦁ stimulants
CLINICAL MANIFESTATIONS
1) Intentional Tremor = postural, bilateral ACTION tremor of the hands, forearms, head, neck or voice
- MC in upper extremities and head; usually spares legs
- WORSENED with emotional stress
- WORSENED with intentional movement
o Finger to Nose test = tremor increases as target is approached
Tremor is shortly RELIEVED with ALCOHOL*
2) No abnormal physical findings
- no significant neurologic findings besides tremor
ESSENTIAL TREMOR TREATMENT
⦁ Propranolol (Indurol) - BB** - may help if severe or situational (Atenolol /Tenormin - BB of choice for those with asthma or bronchospasm)
⦁ Mysoline (Primidone) = barbiturate - anticonvulsant / sedative = given if no relief with Propranolol, given instead of Propranolol, or given with Propranolol
⦁ Gabapentin (Neurontin) - anticonvulsant
⦁ Alprazolam (benzo) = 3rd line
Remeron (Mirtazapine) = antidepressant + for tremor
SURGICAL TREATMENT
ANOREXIA NERVOSA
2 types = Restrictive and Binge / Purge
DSM IV CRITERIA FOR ANOREXIA NERVOSA
⦁ Restriction of energy intake relative to requirements ==> leading to significantly low body weight for her age / sex / developmental trajectory & physical health
⦁ Fear of weight gain
⦁ Severe body image disturbance in which body image is the predominant measure of self-worth with denial of the seriousness of the illness
MC age of onset = mid teens
90% of patients = Women (60% = 15-24y/o)
Frequently seen in athletes, dancers, or other conditions requiring thinness
60% incidence of depression
CLINICAL MANIFESTATIONS
RESTRICTIVE TYPE = reduced calorie intake, dieting, fasting, excessive exercise, diet pills
BINGE/PURGE TYPE = primarily engages in self-induced vomiting, diuretic / laxative / enema use
binge/purge anorexia vs bulimia = For those with binge-purge anorexia, what they are doing results in a net intake lower than their output for long enough to become, or maintain, a too-low weight. For those with bulimia, the net input is enough to maintain or gain weight.
SIGNS/SYMPTOMS ⦁ dry skin ⦁ cold intolerance / hypothermia (hypothyroidism) ⦁ blue hands / feet ⦁ constipation ⦁ bloating ⦁ delayed puberty ⦁ primary or secondary amenorrhea ⦁ fainting ⦁ orthostatic hypotension ⦁ lanugo hair ⦁ scalp hair loss ⦁ early satiety ⦁ weakness / fatigue ⦁ short stature ⦁ osteopenia ⦁ breast atrophy ⦁ atrophic vaginitis ⦁ pitting edema ⦁ cardiac murmurs / sinus bradycardia
DIAGNOSIS
- BMI = 17.5 kg or weight < 85% of ideal weight
PHYSICAL EXAM
o Vital signs - include Orthostatic vitals
o Skin + Extremity evaluation =dryness, bruising, lanugo
o Cardiac Exam = Bradycardia, Arrhythmia, MVP** (heart muscle shrinks but the valves don’t)
o Abdominal Exam
o Neuro Exam - evaluate for other causes of weight loss or vomiting (brain tumor)
LABS
TREATMENT
o medical stabilization: hospitalization if < 75% of ideal body weight, or if patients have medical complications; electrolyte imbalances may lead to cardiac abnormalities, dehydration, arrested growth/development, etc
o Psychotherapy = CBT, supervised meals, weight monitoring
o Pharmacotherapy: if depressed = SSRIs, or atypical antipsychotics - Olanzapine (Zyprexa) - (may also help with weight gain)
o Nutrition
- Goal = to regain 90-92% of ideal body weight
- Inpatient treatment varies by facility
+ oral liquid nutrition
+ nasogastric tube feedings
+ gradual caloric increase with “regular” food - but take it easy during first 2 weeks - so don’t get heart failure + pitting edema
ANOREXIA OUTCOME
o 50% = good outcome - return of menses & weight gain
o 25% = intermediate outcome - some weight regained
o 25% = poor outcome
⦁ associated with later age of onset
⦁ longer duration of illness
⦁ lower minimal weight
⦁ Overall mortality rate = 6.6%. 1/5 anorexia deaths are due to suicide
BULIMIA NERVOSA
Bulimia patients (vs anorexia) = patients with bulimia have NORMAL WEIGHT or are OVERWEIGHT
EPIDEMIOLOGY
DSM IV CRITERIA FOR BULIMIA / clinical manifestations
1) Recurrent BINGE EATING: an episode of binge eating is characterized by BOTH of the following
⦁ Recurrent episodes of eating a large amount of food in a small amount of time (2hrs) = (larger amount of food than what most individuals would eat in a similar period of time)
⦁ A sense of a lack of control over eating during the episode
- **Occurs at least weekly x 3 months
2) Recurrent inappropriate COMPENSATORY BEHAVIORS to prevent weight gain
o Purging Type
⦁ self-induced vomiting
⦁ misuse of laxatives, diuretics, enemas, other meds
o Non-Purging Type ⦁ reduced calorie intake ⦁ dieting ⦁ fasting ⦁ excessive exercise ⦁ diet pills
3) The binge eating & inappropriate compensatory behaviors both occur, on average, at least 1x per week x 3 months
4) Self evaluation is influenced by body shape and weight
5) the disturbance does not occur exclusively during periods of anorexia nervosa
SIGNS/SYMPTOMS OF BULIMIA NERVOSA ⦁ mouth sores ⦁ pharyngeal trauma ⦁ dental caries / teeth pitting / enamel erosion ⦁ Russell's Sign = Calluses on back of knuckles/fingers from sticking hand in mouth to gag ⦁ Heartburn / chest pain ⦁ Esophageal rupture ⦁ Impulsivity: stealing / alcohol abuse / drugs / tobacco ⦁ Muscle cramps ⦁ weakness ⦁ bloody diarrhea ⦁ bleeding or easy bruising ⦁ irregular periods ⦁ fainting ⦁ swollen parotid glands** - Bilateral Parotid Sialadenosis - parotid gland hypertrophy ⦁ Hypotension
parotid gland hypertrophy - attempt to increase saliva release in order to buffer acidity from vomiting
HISTORY
⦁ maximum height & weight
⦁ exercise habits: intensity & hours/week
⦁ stress levels
⦁ habits & behaviors: smoking / alcohol / drugs / sexual activity
⦁ eating attitudes & behaviors
⦁ ROS (review of systems)
PHYSICAL EXAM - BULIMIA
All previous elements +
⦁ Parotid Gland Hypertrophy (if purging type)
⦁ Erosion of teeth enamel (caries) (if purging type)
LABS
TREATMENT FOR BULIMIA
o CBT** is effective! (not very effective with anorexia, but IS effective for bulimia)
o Pharmacotherapy = high success rate (unlike anorexia)
⦁ SSRIs - Fluoxetine (Prozac)** - up to 67% reduction in binge eating, and 56% reduction in vomiting - has been shown to reduce binge-purge cycle, but may have CV SE if electrolyte abnormalities are present
⦁ TCAs
⦁ Topiramate (Topamax) - reduced binge eating by 94% and average weight loss of 6.2 kg (seizure med that is also used to treat migraines, and now bulimia)
⦁ Ondansetron (Zofran) - 24mg/day (often food is associated with vomiting - helps prevent nausea/urge to throw up after - Sublingual available - Dwight prefers this)
**do NOT give Wellbutrin (Bupropion) = (miscellaneous antidepressant) - can lower seizure threshold in bulimics
FEMALE ATHLETE TRIAD
⦁ Eating disorders
⦁ Osteopenia or Osteoporosis (stress fractures)
⦁ Amenorrhea or Oligomenorrhea
Osteopenia = when your bones are weaker than normal but not so far gone that they break easily, which is the hallmark of osteoporosis
Amenorrhea = no menstruation Oligomenorrhea = abnormal menstruation
ERYTHEMA NODOSUM
Erythema nodosum is generally self-limiting and resolves spontaneously within a few weeks. Treat underlying cause